Lataa...
Key differences between apoC-III regulation and expression in intestine and liver
ApoC-III is a critical cardiovascular risk factor, and humans expressing null mutations in apoC-III are robustly protected from cardiovascular disease. Because of its critical role in elevating plasma lipids and CVD risk, hepatic apoC-III regulation has been studied at length. Considerably less is k...
Tallennettuna:
| Julkaisussa: | Biochem Biophys Res Commun |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6069593/ https://ncbi.nlm.nih.gov/pubmed/28739253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2017.07.116 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|